Improving Early Detection and Clinical Management of Bladder Cancer
JCI - Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation | PLOS ONE
Unmet Clinical Needs and Future Perspectives in Non–muscle-invasive Bladder Cancer - European Urology Focus
Recurrent Bladder Cancer - CancerConnect
Tumor Markers - Priority Health
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study - eBioMedicine
Frontiers | Detecting and monitoring bladder cancer with exfoliated cells in urine
Bladder Cancer Biomarkers | Encyclopedia MDPI
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective | Nature Reviews Urology
Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer | Scientific Reports
Dr. Peter Black | Urine Markers for Bladder Cancer | The Ideal Marker
Frontiers | Urinary Markers in Bladder Cancer: An Update
FEP 2.04.07 Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance
Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8: Molecular Therapy
Biological Markers in the Diagnosis of Recurrent Bladder Cancer
Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis - European Urology Focus
Useful and potentially useful urine markers for bladder cancer. | Download Table
Urinary peptide panel for prognostic assessment of bladder cancer relapse | Scientific Reports
![PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54ce5e0004d854229da124b4ed00755e2e2df55b/6-Table1-1.png "PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar")
PDF] Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis | Semantic Scholar
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era | Nature Reviews Urology
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy: Molecular Therapy - Oncolytics
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction - ScienceDirect
Cepheid | Bladder Cancer Monitor Biomarker Test - Xpert Bladder Cancer Monitor
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight - ScienceDirect
Life | Free Full-Text | Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
